Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]
Sashreek Ganguly, Amity University Kolkata There is enormous evidence that inhalation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acts as a major transmission route for coronavirus disease 2019 (COVID-19). It is quintessential to discuss the various routes of viral transmission and ensure efficiency and consistency in guidelines provided to the public. To do this, […]
Ritwika Chowdhury, Team BioXone In today’s times, infections and casualties have become synonymous to the pandemic. People are scared to step out of their houses, if not for an emergency. In such a situation another rising problem that is taking shape gradually is the vision impairment.The WHO theme for World Sight Day 2020 is “hope […]
Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]
